BNB$659.77+0.62%BRENT$93.69-0.09%BTC$74,527+0.15%COPPER$6.53+1.15%DJI$52,759-1.32%DOGE$0.0817+1.18%DXY98.73-0.16%ETH$2,348+0.09%GOLD$4,536+0.46%NDX$29,213-0.72%SILVER$68.95+1.28%SOL$89.62+1.56%SPX$7,641-0.87%US10Y4.70+0.92%VIX16.01+7.52%BNB$659.77+0.62%BRENT$93.69-0.09%BTC$74,527+0.15%COPPER$6.53+1.15%DJI$52,759-1.32%DOGE$0.0817+1.18%DXY98.73-0.16%ETH$2,348+0.09%GOLD$4,536+0.46%NDX$29,213-0.72%SILVER$68.95+1.28%SOL$89.62+1.56%SPX$7,641-0.87%US10Y4.70+0.92%VIX16.01+7.52%
MoneyMarket365.comReal-time markets + AI-ranked and AI-analyzed financial news
·Confidence 95%·Breaking

Moderna Shares Surge 177% on Positive Melanoma Trial Results

HOTMRNA ↑ Very strong

Key takeaways

  • MRNA: MRNA — Very strong bullish
  • Moderna's stock skyrocketed 177% following positive Phase 3 melanoma trial results in collaboration with Merck, prompting investor interest in FDA plans.
#Moderna#Merck#stock market#clinical trials

Analysis

Moderna's stock skyrocketed 177% following positive Phase 3 melanoma trial results in collaboration with Merck, prompting investor interest in FDA plans.

0 likes · 0 dislikes

Comments & Replies

with Google or GitHub to join the discussion.

  • No comments yet be the first to share your view.